4 Patents
- US125655302026Combination Therapy with Targeted 4-1BB (CD137) Agonists/anti-fap Binding Domain and Anti-cea/anti-cd3 Bispecific Antibody
Hoffmann-la Roche Inc.
0 cites - 0 cites
- 0 cites
- US117186802023Combination Therapy of Anti-cd20/anti-cd3 Bispecific Antibodies and 4-1BB (CD137) Agonists
Hoffmann-la Roche Inc.
0 cites